Drug data last refreshed 16h ago · AI intelligence enriched 2w ago
Selenious acid is an intravenous micronutrient supplement containing selenium, an essential trace element required for selenoprotein synthesis and antioxidant defense. It is used in parenteral nutrition formulations to prevent selenium deficiency in patients unable to receive adequate oral intake. The drug provides selenium supplementation to maintain metabolic and immune function in critically ill and nutritionally dependent populations.
Product is in peak commercial phase with stable market position; teams are typically small, focused on hospital/specialty pharmacy channels and compliance maintenance.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
This product offers stable, long-term career positions in niche hospital and specialty pharmacy channels with strong job security through 2041; however, roles are primarily operational and transactional rather than strategic or growth-oriented. Career progression is limited by the commoditized, mature nature of the micronutrient market and the absence of clinical development initiatives.
Worked on SELENIOUS ACID at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/mo